The Sickle Cell Clinical Trials Network: One Year In
The Hematologist Editor-in-Chief, Dr. Laura Michaelis, spoke with Drs. Charles Abrams and Sophie Lanzkron about a groundbreaking ASH initiative started approximate
Popping the Bubble: Promising Results From a Phase I-II Lentiviral Gene Therapy Trial for X-SCID
Drs. Arnold and Teachey review a phase I-II trial observing self-inactivating-lentiviral gene therapy in eight consecutive male infants newly diagnosed with X-linked severe
TRTH 2015 co-directors Drs. Jean Soulier and David M. Bodine talk about the program that provides expert training to a select group of 20 trainees from Europe and North America engaged in research into the mechanisms of hematologic disorders and experimental treatments.
May-June 2019Volume 16, Issue 3
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology